Dr. Brandon M. Henry received his MD from Jagiellonian University in 2016. He was a medical monitor and physician-scientist at Aixial Group from 2022 to 2024. He currently works as a researcher at Cincinnati Children’s Hospital Medical Center and is chair of the International Federation of Clinical Chemistry and Laboratory Medicine SARS-CoV-2 Variants Working Group. He provides scientific, clinical, operational, and regulatory strategy expertise to develop innovative, data-driven, and patient-centered solutions for cell and gene therapy clinical trials.
Research Keywords & Expertise
Clinical Trials
Evidence-based Medicin...
Immunology
Laboratory Medicine
covid-19
Fingerprints
49%
covid-19
5%
Clinical Trials
5%
Laboratory Medicine
5%
Evidence-based Medicine
Short Biography
Dr. Brandon M. Henry received his MD from Jagiellonian University in 2016. He was a medical monitor and physician-scientist at Aixial Group from 2022 to 2024. He currently works as a researcher at Cincinnati Children’s Hospital Medical Center and is chair of the International Federation of Clinical Chemistry and Laboratory Medicine SARS-CoV-2 Variants Working Group. He provides scientific, clinical, operational, and regulatory strategy expertise to develop innovative, data-driven, and patient-centered solutions for cell and gene therapy clinical trials.
Well done!
